• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非典型鞘氨醇 1-磷酸变体,d16:1 S1P,通过 S1P2 激活介导肾细胞癌中 CTGF 的诱导。

The atypical sphingosine 1-phosphate variant, d16:1 S1P, mediates CTGF induction via S1P2 activation in renal cell carcinoma.

机构信息

Institute of General Pharmacology and Toxicology, University Hospital and Goethe University Frankfurt, Germany.

Department of Neurology, University Hospital, RWTH Aachen, Germany.

出版信息

FEBS J. 2022 Sep;289(18):5670-5681. doi: 10.1111/febs.16446. Epub 2022 Apr 3.

DOI:10.1111/febs.16446
PMID:35320610
Abstract

Sphingosine 1-phosphate (S1P) is a lipid mediator with numerous biological functions. The term 'S1P' mainly refers to the sphingolipid molecule with a long-chain sphingoid base of 18 carbon atoms, d18:1 S1P. The enzyme serine palmitoyltransferase catalyses the first step of the sphingolipid de novo synthesis using palmitoyl-CoA as the main substrate. After further reaction steps, d18:1 S1P is generated. However, also stearyl-CoA or myristoyl-CoA can be utilised by the serine palmitoyltransferase, which at the end of the S1P synthesis pathway, results in the production of d20:1 S1P and d16:1 S1P respectively. We measured these S1P homologues in mice and renal tissue of patients suffering from renal cell carcinoma (RCC). Our experiments highlight the relevance of d16:1 S1P for the induction of connective tissue growth factor (CTGF) in the human renal clear cell carcinoma cell line A498 and human RCC tissue. We show that d16:1 S1P versus d18:1 and d20:1 S1P leads to the highest CTGF induction in A498 cells via S1P2 signalling and that both d16:1 S1P and CTGF levels are elevated in RCC compared to adjacent healthy tissue. Our data indicate that d16:1 S1P modulates conventional S1P signalling by acting as a more potent agonist at the S1P2 receptor than d18:1 S1P. We suggest that elevated plasma levels of d16:1 S1P might play a pro-carcinogenic role in the development of RCC via CTGF induction.

摘要

鞘氨醇 1-磷酸(S1P)是一种具有多种生物学功能的脂质介质。“S1P”一词主要指具有 18 个碳原子长链神经酰胺的鞘脂分子,即 d18:1 S1P。丝氨酸棕榈酰转移酶利用棕榈酰-CoA 作为主要底物催化鞘脂从头合成的第一步。经过进一步的反应步骤,生成 d18:1 S1P。然而,丝氨酸棕榈酰转移酶也可以利用硬脂酰-CoA 或肉豆蔻酰-CoA,最终在 S1P 合成途径的末端分别产生 d20:1 S1P 和 d16:1 S1P。我们在患有肾细胞癌(RCC)的小鼠和患者的肾组织中测量了这些 S1P 同系物。我们的实验强调了 d16:1 S1P 在诱导人肾透明细胞癌细胞系 A498 和人 RCC 组织中的结缔组织生长因子(CTGF)中的相关性。我们表明,与 d18:1 和 d20:1 S1P 相比,d16:1 S1P 通过 S1P2 信号导致 A498 细胞中 CTGF 的诱导最高,并且与相邻健康组织相比,RCC 中 d16:1 S1P 和 CTGF 的水平均升高。我们的数据表明,d16:1 S1P 通过作为 S1P2 受体的比 d18:1 S1P 更强效的激动剂来调节传统的 S1P 信号,从而调节 S1P 信号。我们建议,d16:1 S1P 水平升高可能通过诱导 CTGF 在 RCC 的发展中发挥致癌作用。

相似文献

1
The atypical sphingosine 1-phosphate variant, d16:1 S1P, mediates CTGF induction via S1P2 activation in renal cell carcinoma.非典型鞘氨醇 1-磷酸变体,d16:1 S1P,通过 S1P2 激活介导肾细胞癌中 CTGF 的诱导。
FEBS J. 2022 Sep;289(18):5670-5681. doi: 10.1111/febs.16446. Epub 2022 Apr 3.
2
S1P d20:1, an endogenous modulator of S1P d18:1/S1P -dependent signaling.S1P d20:1,S1P d18:1/S1P 依赖性信号的内源性调节剂。
FASEB J. 2020 Mar;34(3):3932-3942. doi: 10.1096/fj.201902391R. Epub 2020 Jan 15.
3
S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation.S1P 通过 S1PR2 介导的 YAP 激活上调 CTGF 表达来刺激增殖。
Mol Cancer Res. 2018 Oct;16(10):1543-1555. doi: 10.1158/1541-7786.MCR-17-0681. Epub 2018 Jun 14.
4
Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells.低密度脂蛋白通过激活系膜细胞中鞘氨醇-1-磷酸受体的反式激活作用诱导结缔组织生长因子的表达。
Mol Endocrinol. 2012 May;26(5):833-45. doi: 10.1210/me.2011-1261. Epub 2012 Mar 15.
5
Induction of antiproliferative connective tissue growth factor expression in Wilms' tumor cells by sphingosine-1-phosphate receptor 2.1-磷酸鞘氨醇受体2诱导肾母细胞瘤细胞中抗增殖结缔组织生长因子的表达
Mol Cancer Res. 2008 Oct;6(10):1649-56. doi: 10.1158/1541-7786.MCR-07-2048.
6
Exogenous S1P via S1P receptor 2 induces CTGF expression through Src-RhoA-ROCK-YAP pathway in hepatic stellate cells.外源性 S1P 通过 S1P 受体 2 通过Src-RhoA-ROCK-YAP 通路诱导肝星状细胞中 CTGF 的表达。
Mol Biol Rep. 2024 Sep 2;51(1):950. doi: 10.1007/s11033-024-09868-w.
7
Myristate-derived d16:0 sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties.豆蔻酸衍生的 d16:0 神经酰胺构成具有独特合成途径和功能特性的心脏神经酰胺库。
J Biol Chem. 2013 May 10;288(19):13397-409. doi: 10.1074/jbc.M112.428185. Epub 2013 Mar 25.
8
PPARγ agonists upregulate sphingosine 1-phosphate (S1P) receptor 1 expression, which in turn reduces S1P-induced [Ca(2+)]i increases in renal mesangial cells.过氧化物酶体增殖物激活受体γ(PPARγ)激动剂上调1-磷酸鞘氨醇(S1P)受体1的表达,进而减少S1P诱导的肾系膜细胞内钙离子浓度([Ca(2+)]i)升高。
Biochim Biophys Acta. 2013 Nov;1831(11):1634-43. doi: 10.1016/j.bbalip.2013.07.011. Epub 2013 Jul 30.
9
Activation of sphingosine 1-phosphate receptor 2 attenuates chemotherapy-induced neuropathy.激活鞘氨醇 1-磷酸受体 2 可减轻化疗引起的周围神经病。
J Biol Chem. 2020 Jan 24;295(4):1143-1152. doi: 10.1074/jbc.RA119.011699. Epub 2019 Dec 27.
10
Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.鞘氨醇 1-磷酸(S1P)受体激动剂通过 S1P2 和 S1P3 受体和非 Smad 依赖性信号通路介导正常肺成纤维细胞的促纤维化反应。
J Biol Chem. 2013 May 24;288(21):14839-51. doi: 10.1074/jbc.M112.426726. Epub 2013 Apr 15.

引用本文的文献

1
Myristic Acid Remodels Sphingolipid Metabolism via Dual Pathways: Canonical d18-Sphingolipid Regulation and Non-Canonical d16-Sphingolipid Synthesis.肉豆蔻酸通过双途径重塑鞘脂代谢:经典的d18-鞘脂调节和非经典的d16-鞘脂合成。
Nutrients. 2025 Sep 5;17(17):2881. doi: 10.3390/nu17172881.
2
Causal impact of genetically determined metabolites on kidney cancer and its subtypes: an integrated mendelian randomization and metabolomic study.基因决定的代谢产物对肾癌及其亚型的因果影响:一项孟德尔随机化与代谢组学整合研究
Am J Cancer Res. 2025 May 15;15(5):2222-2242. doi: 10.62347/VUZH4644. eCollection 2025.
3
Don't Be Surprised When These Surprise You: Some Infrequently Studied Sphingoid Bases, Metabolites, and Factors That Should Be Kept in Mind During Sphingolipidomic Studies.
当这些情况令您惊讶时请别诧异:一些研究较少的鞘氨醇碱、代谢物以及在鞘脂组学研究中应牢记的因素。
Int J Mol Sci. 2025 Jan 14;26(2):650. doi: 10.3390/ijms26020650.
4
The contribution of the sphingosine 1-phosphate signaling pathway to chronic kidney diseases: recent findings and new perspectives.鞘氨醇 1-磷酸信号通路在慢性肾脏病中的作用:最新发现与新视角。
Pflugers Arch. 2024 Dec;476(12):1845-1861. doi: 10.1007/s00424-024-03029-5. Epub 2024 Oct 9.
5
Atypical sphingosine-1-phosphate metabolites-biological implications of alkyl chain length.非典型鞘氨醇-1-磷酸代谢物-烷基链长的生物学意义。
Pflugers Arch. 2024 Dec;476(12):1833-1843. doi: 10.1007/s00424-024-03018-8. Epub 2024 Sep 19.
6
Cross-Regulation of the Cellular Redox System, Oxygen, and Sphingolipid Signalling.细胞氧化还原系统、氧气和鞘脂信号的交叉调节
Metabolites. 2023 Mar 14;13(3):426. doi: 10.3390/metabo13030426.
7
Lipids as Targets for Renal Cell Carcinoma Therapy.脂质作为肾癌治疗的靶点。
Int J Mol Sci. 2023 Feb 7;24(4):3272. doi: 10.3390/ijms24043272.
8
Novel Thieno [2,3-]pyridine Anticancer Compound Lowers Cancer Stem Cell Fraction Inducing Shift of Lipid to Glucose Metabolism.新型噻吩并[2,3-]吡啶抗癌化合物降低癌症干细胞比例,诱导脂质至葡萄糖代谢转变。
Int J Mol Sci. 2022 Sep 28;23(19):11457. doi: 10.3390/ijms231911457.